Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LX211 in active non-infectious uveitis (LUMINATE)
NCT00404612Phase 3Completed
- Sponsor
- Lux Biosciences, Inc.
- Start
- Jan 2007
- Primary completion
- Nov 2008
- Countries
- 7
01
Overview
A Phase 3 trial of voclosporin in noninfectious uveitis (NIU), sponsored by Lux Biosciences, Inc.. Started Jan 2007; status: completed.
02
Drugs
voclosporin
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT00404612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404612.